Web Stats Provided By Google Analytics

Wednesday, April 30, 2014

Synergy Pharmaceuticals Announces Positive Results of Plecanatide...

Synergy Pharmaceuticals Inc. today announced positive top-line results from a phase 2b dose-ranging study assessing plecanatide's safety and efficacy in 424 patients with irritable bowel syndrome with constipation .

http://ift.tt/S9BzRw

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts